Company
Apim Therapeutics
APIM Therapeutics. Disabling Cancer's Ability to Escape Treatment
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Develops drug candidate for treatment of cancer based on novel intervention point PCNA which is critical in the regulation of cellular stress responses.
Loading relationship preview